Literature DB >> 9493561

Abnormal kidney function as a cause and a consequence of obesity hypertension.

J E Hall1, M W Brands, J R Henegar, E W Shek.   

Abstract

1. Obesity is the most common nutritional disorder in the US and is a major cause of human essential hypertension. Although the precise mechanisms by which obesity raises blood pressure (BP) are not fully understood, there is clear evidence that abnormal kidney function plays a key role in obesity hypertension. 2. Obesity increases tubular reabsorption and this shifts pressure natriuresis towards higher BP. The increased tubular reabsorption is not directly related to hyperinsulinaemia, but is closely linked to activation of the sympathetic and renin-angiotensin systems, and possible changes in intrarenal physical forces caused by medullary compression due to accumulation of adipose tissue around the kidney and increased extracellular matrix within the kidney. 3. Obesity is also associated with marked renal vasodilation and increased glomerular filtration rate, which are compensatory responses that help overcome the increased tubular reabsorption and maintain sodium balance. However, chronic renal vasodilation causes increased hydrostatic pressure and wall stress in the glomeruli which, along with increased lipids and glucose intolerance, may cause glomerulosclerosis and loss of nephron function in obese subjects. Because obesity is a primary cause of essential hypertension as well as type II diabetes, there is good reason to believe that obesity may also be the most frequent cause of end-stage renal disease. 4. Future research is needed to determine the mechanisms by which excess weight gain activates the neurohumoral systems and alters renal structure and function. Because of the high prevalence of obesity in most industrialized countries, unravelling these mechanisms will likely provide a better understanding of the pathophysiology of human essential hypertension and chronic renal failure.

Entities:  

Mesh:

Year:  1998        PMID: 9493561     DOI: 10.1111/j.1440-1681.1998.tb02146.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  17 in total

1.  Pathology of renal complications in obesity.

Authors:  A H Cohen
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

2.  Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Stacy A Porter; Joseph M Massaro; Udo Hoffmann; Caroline S Fox
Journal:  Hypertension       Date:  2011-09-19       Impact factor: 10.190

Review 3.  Mechanisms of pressure natriuresis.

Authors:  Joey P Granger; Barbara T Alexander; Mayte Llinas
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 4.  Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity.

Authors:  Alejandro R Chade; John E Hall
Journal:  Am J Nephrol       Date:  2016-10-22       Impact factor: 3.754

Review 5.  Pathophysiology of obesity hypertension.

Authors:  J E Hall
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

6.  Obesity, blood pressure, and renal sodium handling.

Authors:  M H Weinberger
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 7.  The effect of weight loss in obesity and chronic kidney disease.

Authors:  Enrique Morales; Manuel Praga
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

8.  Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke.

Authors:  Christian Deutsch; Vera Portik-Dobos; Anita D Smith; Adviye Ergul; Anne M Dorrance
Journal:  Microvasc Res       Date:  2009-04-15       Impact factor: 3.514

Review 9.  Optimizing blood pressure control in the obese patient.

Authors:  Tobias Pischon; Arya M Sharma
Journal:  Curr Hypertens Rep       Date:  2002-10       Impact factor: 5.369

10.  Epidemiology of hypertension and cardiovascular disease in African Americans.

Authors:  John M Flack; Kieth C Ferdinand; Samar A Nasser
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.